The company had focused its resources on Filspari’s launch in IgAN after the US FDA snubbed the therapy in another rare ...

German life science company Evotec has announced a collaboration with X-Chem to accelerate early-stage drug ...

Representatives of the WHO and the IFRC called for international cooperation to tackle the current mpox outbreak.

Following discussions to finalise rilparencel’s regulatory plans in the US, North Carolina-based ProKidney will drop the ...

The powerful sedative xylazine has been detected in cannabis vapes. Credit: PavelKant/Shutterstock. The UK government has ...

A study suggests that children may face a higher risk of harm if their father is using valproate at the time of conception.

Biogen plans to apply for regulatory approval of this investigational dose regimen following positive trial data.

The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD-147 aimed at neuroendocrine carcinoma.

The US FDA has approved Amneal Pharmaceuticals and Shilpa Medicare’s oncology product BORUZU for subcutaneous administration.

NImmune Biopharma and BioTherapeutics have partnered to develop new precision medicines in the field of inflammation and ...

ArsenalBio has closed an oversubscribed Series C financing round, securing $325m to propel its programmable cell therapy ...

Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 low to middle-income ...